2019 Targeted Radionuclide Therapy Consortjum University of Wisconsin - PDF document

2019 Targeted Radionuclide Therapy Consortjum University of Wisconsin - Madison UW Memorial Union - Great Hall Friday, Sept 20 th - Sunday, Sept 22 nd , 2019 Contact Justjn Jefgery with questjons jjjefgery@wisc.edu

TRTC 2019 Agenda Friday, Sept 20, 2019 - Memorial Union - Great Hall Introductjon & Social Event 3:00 - 4:00pm Registratjon 4:00 - 5:00pm Introductjon & Conference Overview 5:00 - 10:30pm Pyle Alumni Lounge/Pyle Roofuop Terrace Saturday, Sept 21, 2019 - Memorial Union - Great Hall Session 1: Radiochemistry, Isotopes & Supply ( Moderator: Reinier Hernandez, PhD) 7 - 7:30am Shutule to Memorial Union 7:30am Breakfast - Provided at the Memorial Union Jamey Weichert , PhD - University of Wisconsin 7:45 - 8am Introductjon and welcome 8 - 8:30am Jon Engle , PhD - University of Wisconsin 8:30 - 9am Scotu Wilbor , PhD - University of Washington 9 - 9:30am Cathy Cutler , PhD - Brookhaven Natjonal Laboratory 9:30 - 10am Break - Cofgee/Refreshments 10 - 10:30am Alejandro Amor , PhD - Albert Einstein College of Medicine 10:30 - 11am Gregory Severin , PhD - Michigan State University Session 2: Emerging Agents & Applicatjons (Moderator: Jacek Capala, PhD) 11 - 11:30am Frank Lin, MD - Natjonal Instjtutes of Health 11:30 - 12pm Steve Larson , MD - Memorial Sloan Ketuering Cancer Center 12 - 1pm Lunch - Provided at the Memorial Union

TRTC 2019 Agenda 1 - 1:30pm Daniel Pryma , MD - University of Pennsylvania 1:30 - 2pm Michael Schultz , PhD - University of Iowa 2 - 2:30pm Lilja Bjork Solnes , MBA, MD - Johns Hopkins University 2:30 - 3pm Break - Cofgee/Refreshments 3 - 3:30pm Carolyn Anderson , PhD - University of Pitusburgh Rob Hobbs , PhD - Johns Hopkins University 3:30 - 4pm Frontjers in RPT Dosimetry: Small scale modeling and combinatjon therapies 4 - 4:30pm Zach Morris , MD, PhD - University of Wisconsin 5 - 10p Gala Dinner - Fresco (227 State St., Madison, WI 53703) Sunday, Sept 22, 2019 - Memorial Union - Great Hall Session 3: Imaging & Advanced Dosimetry (Moderator: Joseph Grudzinski, PhD) 7 - 7:30am Shutule to Memorial Union 7:30am Breakfast - Provided at the Memorial Union 8 - 8:30am Brian Miller , PhD - University of Colorado 8:30 - 9am Yuni Dewaraja , PhD - University of Michigan 9 - 9:30am Bryan Bednarz, PhD - University of Wisconsin 9:30 - 10am Break - Cofgee/Refreshments 10 - 10:30am Youngho Seo , PhD - University of California San Francisco 10:30 - 11am John Humm , PhD - Memorial Sloan Ketuering Cancer Center Imaging and Dosimetry of alpha - emittjng radionuclides

Session 4: Clinical Translatjon, Regulatory & Reimbursement (Moderator: Yusuf Menda, MD) 11 - 11:30am Xiaoyuan (Shawn) Chen , PhD - Natjonal Instjtutes of Health 11:30 - 12pm David Bushnell , MD - University of Iowa 12 - 1pm Lunch - Provided at the Memorial Union Kellie Bodeker - University of Iowa 1 - 1:30pm Real regulatjons and consideratjons: combinatorial INDs, the single IRB mechanism, and pooling data from multjple sites 1:30 - 2pm Steve Cho , MD - University of Wisconsin 2 - 2:30pm Neeta Pandit - Taskar , MD - Memorial Sloan Ketuering Cancer Center 2:30 - 3pm Bonnie Clark - Society of Nuclear Medicine and Molecular Imaging 3 - 3:30pm Michael Graham , MD, PhD - University of Iowa Jamey Weichert , PhD - University of Wisconsin 3:30 Closing Remarks Sponsors

2019 Targeted Radionuclide Therapy Consortjum University of Wisconsin - PDF document

2019 Targeted Radionuclide Therapy Consortjum University of Wisconsin - Madison UW Memorial Union - Great Hall Friday, Sept 20 th - Sunday, Sept 22 nd , 2019 Contact Justjn Jefgery with questjons jjjefgery@wisc.edu TRTC 2019 Agenda Friday, Sept 20,

Radioactive Synovectomy (RS) in Haemophilia Thynn Thynn Yee RS Local form of radionuclide

IMAGE-BASED PATIENT-SPECIFIC DOSIMETRY FOR RADIONUCLIDE THERAPY Michael Ljungberg, PhD,

Characterization Approaches for Radionuclide-Contaminated Radionuclide Contaminated Subsurface

Best Use of Osteoclast-Targeted Therapy Matthew R. Smith, M.D., Ph.D. Professor of Medicine,

Will drugs targeted to genetic and epigenetic defects become the best future option in therapy of

Is there a role for targeted therapy in the adjuvant or neoadjuvant setting? Nathan Pennell,

Occupational therapy with children: introduction to universal, targeted and specialist services

neuroendocrine tumors Daa filigoj, Petra Tome, Luka Jensterle 13. maj, 2015 Department of

The Emergence of Targeted Therapy for Patients with Metastatic Colorectal Cancer (mCRC) and BRAF

Epigenetic Targeted Therapy in AML Martin S. Tallman, M.D. Chief, Leukemia Service Memorial

Molecular pathology of ameloblastoma: towards targeted therapy IAOP and AAOMP Joint Meeting

Radiation Toxicity in Era of Combined Modality Therapy with Targeted Agents Christopher J. Anker,

Targeted Gene Therapy in the Treatment of X-linked Hyper-IgM Syndrome Caroline Kuo, MD Pediatric

Adjuvant Therapy of Thyroid Cancer: rhTSH, RAI, EBRT and Targeted Therapeutics October 13, 2018

Pharmacogenomic markers in EGFR-targeted therapy of lung cancer Rafal Dziadziuszko, MD, PhD

WG 5: Radionuclide Transfer to wildlife EMRAS II Jan 2011 TRS: RADIONUCLIDE TRANSFER TO

Is it possible to stop treatment with the new targeted therapies? Peter Hillmen

Radium-223 and Targeted Alpha Therapy Thinking About Tomorrow Oliver Sartor, M.D. Laborde

Clinical trial design in the current age of immunotherapy and targeted therapy Martijn Lolkema,

Targeted Charging Review Final Decision Andrew Self / Kayt Button 17/12/2019 How does the

MUSIC THERAPY MUSIC THERAPY What is music therapy? Music therapy is simply the process of using

3/11/2017 TARGETED TREATMENTS FOR PHVD SESSION 7: Antagonists Prostacyclins Endothelin

Radionuclide production measurements at the INFN LNL Giacomo Germogli INFN Section of Ferrara

Preclinical imaging and therapy Marion de Jong Content Introduction to raise awareness about